Immunosuppressive agent: A medication that depresses or halts immune system activity. For example, immunosuppressive agents may be given to prevent the body from forming an immune response to an organ transplant or to treat a disease that is caused by an overactive immune system, such as rheumatoid arthritis.
This report contains market size and forecasts of Immunosuppressive Agents in global, including the following market information:
Global Immunosuppressive Agents Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Immunosuppressive Agents Market Sales, 2017-2022, 2023-2028, (Kiloton)
Global top five Immunosuppressive Agents companies in 2021 (%)
The global Immunosuppressive Agents market was valued at 21540 million in 2021 and is projected to reach US$ 45590 million by 2028, at a CAGR of 11.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Cyclosporin Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Immunosuppressive Agents include Huadong Medicine, Fujisawa Pharmaceutical Co Ltd, Astellas, Roche, Novartis and North China Pharmaceutical Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Immunosuppressive Agents manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Immunosuppressive Agents Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Immunosuppressive Agents Market Segment Percentages, by Type, 2021 (%)
Cyclosporin
Tacrolimus
Everolimus
Sirolimus
Mycophenolic Acid
Global Immunosuppressive Agents Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Immunosuppressive Agents Market Segment Percentages, by Application, 2021 (%)
Innate Immune Disease Treatment
Organ Transplant
Cancer Treatment
Other
Global Immunosuppressive Agents Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Immunosuppressive Agents Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Immunosuppressive Agents revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Immunosuppressive Agents revenues share in global market, 2021 (%)
Key companies Immunosuppressive Agents sales in global market, 2017-2022 (Estimated), (Kiloton)
Key companies Immunosuppressive Agents sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Huadong Medicine
Fujisawa Pharmaceutical Co Ltd
Astellas
Roche
Novartis
North China Pharmaceutical Group